Image

Offsetting Hippocampal Degeneration in m-sTBI

Recruiting
18 - 65 years of age
Both
Phase N/A

Powered by AI

Overview

The goal of this study is to establish the feasibility of an intervention designed to improve memory in patients who have experienced a moderate or severe traumatic brain injury (m-sTBI) and to examine its effect on brain structures.

Description

The purpose of this study is to establish the feasibility of a novel intervention, and explore biomarker predictors of neurodegeneration and response to the proposed intervention. This 16 week intervention utilises allocentric spatial navigation tasks to improve memory and counteract hippocampal neurodegeneration. This intervention will be administered in combination with neuropsychological assessments, MR imaging, and the analysis of genomic variants at two time points; 7 months post-TBI and 12 months post-TBI.

Eligibility

Inclusion Criteria:

  • An acute care diagnosis of TBI as determined by a medical professional, indicated by:
    • Post-traumatic amnesia duration of 24 hours or more, and/or lowest Glasgow Coma Scale score of < 13
    • Positive clinical CT or MRI scan
  • Aged 18 to 65
  • Fluent in English
  • Have the competency for fully informed consent by 6 months post-injury
  • Have basic computer skills
  • Have functional use of one upper extremity
  • Have access to the internet

Exclusion Criteria:

  • A neurological disorder other than TBI (e.g., stroke, dementia, tumor, neurodevelopmental disorder) impairing baseline awareness, cognition, or validity of follow-up and outcome assessment.
  • A systemic condition (e.g., lupus, diabetes, rheumatoid arthritis).
  • Any contraindications to magnetic resonance imaging (MRI)
  • You are experiencing language impairments (i.e., aphasia) from your injury

Study details

Traumatic Brain Injury, Degeneration, Memory; Loss, Mild, Following Organic Brain Damage

NCT03727334

University of British Columbia

25 January 2024

Step 1 Get in touch with the nearest study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer  to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact

site

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.